Delivery Order SPE2DB20D3104-SPE2DB24FV4N6

The U.S. Defense Logistics Agency has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 4,563,581,796 units of the pharmaceutical product NovaSeven RT 2 mg vials. The $27,604.30 contract has a completion date of February 29, 2024. AmerisourceBergen Drug Corp, a for-profit organization, serves as the prime contractor and has received numerous similar awards from the DLA Troop Support Medical to...

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 2 mg vials of the medication NovoSeven RT, with a ceiling value of $2,760.43 and an ultimate completion date of December 2, 2024. The contract is a firm fixed-price delivery order, and there is no set-aside designation, indicating open competition. AmerisourceBergen holds a large...

The Defense Logistics Agency Troop Support Medical awarded a $5,520.86 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 2 mg NovoSeven RT vials. This delivery order was awarded under an existing contract and does not have a set-aside designation. Amerisourcebergen Drug Corp, as a prime contractor, has previously provided a range of pharmaceutical products and medical supplies to support DLA's military treatment...

This federal contract award is for the delivery of NovoSeven RT 5 mg vials to the Defense Logistics Agency (DLA). The $80,051.84 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 14, 2025, with a completion date of April 4, 2025. This award is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a...

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $42,900.96 Firm Fixed Price delivery order contract is for the supply of NovoSeven RT 5 mg vials, a specialty medication. The contract has an ultimate completion date of December 23, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...

This federal contract award, valued at $6,911.29, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of NovoSeven RT 5 mg vials, a pharmaceutical product. This award is a delivery order under a single-award Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This IDC...

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of NovoSeven RT 5 mg vials, a medication used to treat hemophilia. The contract has a ceiling value of $34,556.45 and runs through July 1, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December...

Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a $27,094.90 firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical to supply 4562731451 NOVOSEVEN RT 2 MG VIALS. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with all supplies delivered by November 29, 2023. This order was awarded under an existing indefinite-delivery contract with no set-aside designation specified. As a...

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $8,238.22 for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML medical products. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of January 28, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...

Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical to provide NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product, with a potential value of $1,628.18. This delivery order is part of an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, valued up to $999,999,999.00 through December 2025. The IDC serves as the...